| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |